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It is estimated that people with diabetes have two to three 
times greater prevalence of depressive symptoms than those 
without diabetes (Anderson, Freedland, Clouse, & Lustman, 
2001; Lustman & Clouse, 2005). For those persons living with 
diabetes, depression has potential negative consequences 
for diabetes complications, comorbidities, and mortality (de 
Groot, Anderson, Freedland, Clouse, & Lustman, 2001). How-
ever, questions remain regarding the nature and direction of 
this relationship. Living with a chronic disease is a stressor 
that can negatively impact psychological well-being; yet, there 
is also increasing evidence that premorbid depression is a risk 
factor for the onset of Type 2 diabetes (Arroyo et al., 2004; 
Carnethon, Kinder, Fair, Stafford, & Fortmann, 2003; Eaton, 
2002; Everson-Rose et al., 2004; Palinkas, Lee, & Barrett-Con-
nor, 2004). Previous work on depression and diabetes has been 
largely cross-sectional and has inferred causal relationships by 
comparing across people or has looked at change, but usually 
over a relatively long period of time (months or years). This 
typical macroanalytic perspective links diagnostic categories 
of depression with global measures of glucose control such 
as HbA1C. HbA1C represents a time weighted average blood 
glucose concentration over a 3-month period.
In this study, we asked how depressive affect and glucose 
may be related by adjusting our lens to focus on the day-to-
day lives of persons living with diabetes. The study presented 
here takes a microanalytic view of mood and blood glucose, 
using daily diary methodology to examine positive and nega-
tive affect in relation to blood glucose over a 21-day period in 
the lives of persons with Type 2 diabetes.
Positive and Negative Affect and Health
Just as depression has been clearly shown to be related to 
diabetes and to health in general, there is a growing literature 
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Abstract
Objective: To examine the relationship between mood and blood glucose in a 21-day daily diary study. 
Design: During a home visit, information was gathered from 206 persons with Type 2 diabetes regarding demographics, disease characteris-
tics and treatment, and depressive symptoms. They had blood drawn at a laboratory, yielding HbA1C. The participants were then tele-
phoned each evening for 21 days and were asked about their positive and negative mood during the past 24 hours. They also tested their 
blood glucose upon rising in the morning. 
Main Outcome Measures: The main outcomes measures were positive and negative affect and fasting glucose. 
Results: Multilevel analyses revealed a relationship between negative affect on one day and morning glucose on the next day. There was no 
such relationship between positive affect and glucose, nor was there a comparable effect of glucose on one day and either positive or neg-
ative affect on the next day. 
Conclusion: The observed relationship between mood and blood glucose appears to be because of negative affect, not positive, with no evi-
dence of a lagged effect of glucose on mood.
Keywords: negative affect, positive affect, diabetes, mood, glucose
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linking both positive and negative affect to health outcomes. 
Whereas in health literature, depression is more often viewed 
in terms of DSM–IV diagnostic categories and their clinical im-
plications, it is likely as well that subclinical depressive symp-
toms, distress, mood, and affect may have implications for 
health outcomes and the general well-being of patients with 
diabetes. For example, Fisher and colleagues (2007) reported 
higher HbA1C among those scoring above a cutoff of 16 and 
greater on the CES-D, compared to those <16, but no relation-
ship between major depressive disorder (MDD), using a diag-
nostic interview, and HbA1C.
Measures of affect usually differ from measures of depres-
sion not only in the time frame and persistence of specific feel-
ings, but also in the breadth of emotions reflected in the mea-
sures. Many measures of affect include both positive affect (PA) 
and negative affect (NA), usually viewed as two distinct, orthog-
onal dimensions, rather than opposite ends of a bipolar dimen-
sion. The constructs of positive and negative affect refer more 
to what Denollet & de Vries (2006) define as “subjective moods 
and feelings” (p. 172). They characterize positive affect as pleas-
ant engagement with the environment, including such feelings 
as happiness, excitement, and contentment. Negative affect re-
flects distress and unpleasant reaction to the environment, in-
volving such feelings as anger, fear, sadness, and nervousness.
Watson’s Positive and Negative Affect Scale (PANAS) 
(Watson, Clark, & Tellegen, 1988) was designed to measure or-
thogonal dimensions of positive and negative affect and has 
been widely used in studies of affect and health. When related, 
NA and PA are usually negatively correlated, although the 
strength of the correlation varies. Some of the variability in the 
relationship between the two is probably related to the time 
frame used as well as the intensity of the feelings (Pressman & 
Cohen, 2005; Watson, Wiese, Vaidya, & Tellegen, 1999). Daily 
measures of PA and NA tend to be less related to each other, 
partly because of the typically low to moderate levels of affect 
reported (Watson et al., 1999). The exception is in situations of 
high intensity, where an extreme in one would be incompati-
ble with the other. When the time frame is longer, the correla-
tions may be higher.
Depending on the time frame, affect can either reflect a rel-
atively fleeting mood (state affect) or a more stable character-
istic of the individual (trait affect). Generally, questions mea-
suring state affect are framed “in the last day” or “currently,” 
whereas trait affect is usually framed “in the last few weeks” 
or “generally” (Pressman & Cohen, 2005). Of course, in daily 
studies as long as the present one (21 days), daily state affect 
measured repeatedly over several weeks might approach a 
typical or trait affect for the individual. A daily diary format 
allows many of the questions regarding characteristics of af-
fect to be addressed in terms of how people differ in their av-
erage levels of PA and NA across the 21 days as well as how 
individuals vary day to day.
How are NA and PA related to depression? In most stud-
ies, affect and depressive symptoms are correlated. For exam-
ple, Denollet and de Vries (2006) report a correlation of .58 be-
tween NA on the PANAS and depression as measured by the 
Centers for Epidemiologic Studies Depression scale (CES-D). 
Very similar results were reported by Watson et al. (1988) be-
tween the PANAS NA scale and the Beck Depression Inven-
tory (r = .57). Although there is far less information on positive 
affect, Watson et al. report correlations ranging from −.19 to 
−.36 between PA and depression symptom scales, depending 
on the depression scale and the time frame used. In a study of 
older persons that examined both daily affect and depression 
(CES-D), those who were categorized as having either “ma-
jor depression” or “other depression” on the CES-D exhibited 
more NA and less PA (Chepenik et al., 2006). However, the 
authors report that even among those with major depression, 
there was a great deal of day-to-day variability in NA.
Similar to the models proposed for the relationship between 
depression and health (e.g., Cohen, Kessler, & Gordon, 1995; 
Kiecolt-Glaser & Glaser, 2002), the pathways between negative 
and positive affect and health outcomes may operate through 
behavioral and/or biological mediators, both of which have 
relevance for diabetes. Pressman and Cohen (2005) propose 
two models for the links between positive affect and health, 
although one might assume that such models would apply 
to negative affect as well. First, they suggest that affect has a 
direct effect on both behaviors and physiology. More specif-
ically, they hypothesized that positive affect should result in 
better health behaviors and better adherence to treatment reg-
imens. Direct physiological effects could include autonomic 
nervous system activation, HPA axis activation (decreased 
cortisol), and an effect on immune functioning (Kiecolt-Glaser, 
McGuire, Robles, & Glaser, 2002; Taylor, Repetti, & Seeman, 
1997). Indeed, some evidence exists for a moderating effect of 
NA on the relationship between PA and natural killer cell ac-
tivity (Valdimarsdottir & Bougjerg, 1997).
In general, evidence is mixed regarding the effects of both 
positive and negative affect on health. Pressman and Cohen 
(2005) summarize the literature as showing that, in general, 
higher PA is related to lower mortality and morbidity, but 
point out that the data are often conflicting. Steptoe and War-
dle (2005) found significant relationships for PA in the form 
of lower salivary cortisol, reduced fibrinogen stress response, 
and lower ambulatory heart rate (in men only) in an examina-
tion of data from the Whitehall study. Looking at NA in rela-
tionship to cardiovascular outcomes in a daily study, Kamarck, 
Schwartz, Shiffman, Muldoon, Sutton-Tirell, and Janicki (2005) 
differentiated between negative affect (valence) and arousal 
(activation) and found that NA was not related to heart rate 
changes, but arousal was.
There appears to be little evidence on the relationship be-
tween affect and blood glucose levels. In a study of adults 
with Type I and Type 2 diabetes, Trief, Himes, Orendorff, and 
Weinstock (2001) reported that high scores on the PANAS 
NA scale were related to more reported health problems and 
poorer marital quality. Although they found that marital qual-
ity was not significantly related to HbA1C, they did not report 
the relationship between affect and glycemic control. Yancura 
and colleagues (Yancura, Aldwin, Levenson, & Spiro, 2006) 
found no relationship between NA and fasting glucose in a 
study of metabolic syndrome, but PA was related to glucose. 
In a review article of research on affect and biological markers 
of health, Ryff et al. (2006) found evidence for a relationship 
between NA (but not PA) and glycemic control. In conclusion, 
the evidence is mixed for both PA and NA in their relationship 
to health, suggesting the need for a closer look at both affect 
and diabetes outcomes.
Daily Diary Studies
Daily (microanalytic) studies have increased in number in 
recent years because this type of methodology allows for both 
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nomothetic (between person) and idiographic (within person) 
perspectives (Almeida, 2005; Tennen, Affleck, & Armeli, 2005). 
Between person comparisons can tell us about how average 
levels of mood are related to average levels of glucose, whereas 
within-person analyses offer the opportunity to examine how 
intra individual variability in one variable (affect) is related to 
intra individual variability in another (glucose). For example, 
Charles and Almeida (2006) examined the relationship of af-
fect with pain and respiratory and gastrointestinal (GI) symp-
toms in a daily diary study. They found both concurrent re-
lationships and lagged relationships between negative affect 
and symptoms. All three types of symptoms were related to 
current state negative affect.
Although the number of daily studies has grown, there is 
little research to date examining daily variability in mood and 
glycemic control. Bode, Schwartz, Stubbs, and Block (2005) 
used continuous monitors over a 21-day period with partici-
pants with both Type I and Type 2 diabetes and reported con-
siderable variability both within and between participants 
in blood glucose levels. The relationship between blood glu-
cose variability and mood was examined in a daily study by 
Gonder-Frederick, Cox, Bobbitt, and Pennebaker (1989) in-
volving 34 adults with Type 1 diabetes. Both positive and neg-
ative affect were measured four times each day, just before 
measuring blood glucose. In general, the authors reported that 
both positive and negative mood were related to blood glu-
cose, although they described the relationships as “highly id-
iosyncratic,” that is, the relationships varied across mood and 
among items used to measure mood.
In summary, the literature supports the relationship be-
tween mood/depression and diabetes outcomes, but the direc-
tion and strength of the relationship remains uncertain. Little 
evidence exists linking day-to-day mood and glucose. In the 
current study, we take a close-up view over 21 days of the re-
lationship between mood and blood glucose. The benefits of 
this approach are that it allows us to tease out the mood/glu-
cose relationships through multiple measures over time in a 
far more detailed manner than allowed in more macrolongitu-
dinal research. Furthermore, it allows us to separate trait pat-
terns from variations in mood state, observe the emergence of 
idiographic patterns, and test for moderators on the resulting 
patterns of relationship.
Adults with Type 2 diabetes participated in a 21-day 
daily study, in which they answered questions about posi-
tive and negative mood and tested their blood glucose. We 
asked, does negative or positive affect influence blood glu-
cose and/or does blood glucose influence negative or posi-
tive affect over time? For both types of mood, there are two 
separate questions involving the between-person and within-
person elements of the predictors. Our primary questions in-
clude the following: 
1. Between persons: 
 a. Are those higher in mean level of negative affect across 
the 21 days also higher in mean blood glucose?
 b. Are those higher in mean level of positive affect across 21 
days lower in mean blood glucose?
2. Within person: 
 a. Are those higher than usual in negative affect on one day 
higher than usual in fasting blood glucose on the follow-
ing morning?
 b. Are those higher than usual in positive affect on one day 
lower than usual in fasting blood glucose on the follow-
ing morning?
 c. Are those higher than usual in blood glucose on one day 
higher than usual in negative affect on the next day?
 d. Are those higher than usual in blood glucose on one day 
lower than usual in positive affect on the next day?
In addition, we ask how stable between-person characteristics 
affect mean glucose levels and how they moderate the rela-
tionship between within-person affect and glucose.
Method
Participants
Participants for the daily study were drawn from a larger 
longitudinal study of depression, diabetes management, and 
glycemic control (Fisher et al., 2007). The longitudinal study 
participants were recruited from community-based Bay Area 
medical groups and diabetes centers. Inclusion criteria in-
cluded a diagnosis of Type 2 diabetes, ages 21 to 75; English- 
or Spanish-speaking; no severe diabetes complications or seri-
ous comorbidities.
Longitudinal study participants who entered that study be-
fore or during the recruitment period for the diary study were 
eligible for the diary study if they were English-speaking. Of 
the 452 persons who were eligible, 206 agreed to participate 
in the daily diary study (50%). Participants in the diary study 
were paid $135 ($35 for the first week, $45 for the second, and 
$55 for the third week) for their participation. Demographic 
and disease related characteristics for both the diary sample 
and the 246 English-speaking nondiary participants in the lon-
gitudinal study are presented in Table 1. The two samples did 
not differ significantly on any of these characteristics. 
 
Table 1. Characteristics of Diary and Nondiary Participants (Eng-
lish Speaking)
                                                       Diary                 Nondiary
                                                    (N = 206)              (N = 246)
                                           Mean          (SD)       Mean        (SD)      p-level
Female  58.7%   54.5%   0.36
Age  57.84  (9.13)  57.74  (10.53)  0.92
Education (yrs)  14.96  (2.70)  15.41  (2.72)  0.08
Ethnicity      0.63
Asian  20.4%   17.5%
African-American  22.8%   22.8%
Latino  10.2%   9.8%
European-American  37.9%   43.9%
Other  8.7%   6.1%
Years since diagnosis  8.00  (7.07)  8.34  (7.98)  0.64
HbA1C (%)  7.22  (1.35)  7.12  (1.32)  0.42
Diabetes management      0.26
Diet/exercise only  13.6%   17.1%
Oral meds only  70.4%   68.7%
Insulin only  8.3%   4.5%
Oral meds & insulin  7.8%   9.8%
BMI  33.19  (7.94)  32.44  (7.74)  0.31
CES-D  10.49  (10.45)  10.51  (10.26)  0.98
Major Depression Dx  8.3%   10.2%   0.49
p-level based on χ2 or t test. N of cases varied slightly for those with 
numbers in last column: Educ, HbA1c, CESD, & MDD.
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Baseline Interviews, Questionnaires, and Biological Measures
Participants completed questionnaires and were inter-
viewed during a home visit lasting approximately 1.5 hours. 
During that visit, height and weight were measured from 
which body mass index (BMI) was calculated. In an inter-
view, they were asked about the medications used to manage 
their diabetes and how long ago they had been diagnosed 
with diabetes (TDX). Diabetes medications were dummy 
coded into four categories (diet and exercise only, oral med-
ications only, and both oral medications and insulin) with 
those on insulin only as the comparison group. They also vis-
ited a laboratory where a blood sample was collected, yield-
ing hemoglobin A1C (HbA1C), a measure of glycemic control 
representing the percent of hemoglobin molecules circulat-
ing in the blood that contain sugar (<7% is generally consid-
ered desirable for persons with Type 2 diabetes). A question-
naire asked about demographics including sex (1 = female), 
age, education (years completed), and self-identified ethnic-
ity. Ethnicity was dummy coded into five categories (Asian, 
African American, Latino, Other) with Whites as the compar-
ison group.
Depressive affect was measured with the Center for Epide-
miological Studies Depression scale (CES-D) (Radloff, 1977), 
a 20 item measure asking about symptoms experienced in the 
past week (scores ranged from 0 to 60). The alpha for this sam-
ple was .84. Trained interviewers administered the Composite 
International Diagnostic Interview (CIDI) from which a diag-
nosis for Major Depressive Disorder (MDD) (Wittchen, 1994) 
was derived. For these analyses, a dichotomous variable was 
created where 1 indicates a diagnosis of MDD in the past year 
and 0 represents no MDD.
Daily Diary Participants
Participants ranged in age from 30 to 75, with a mean age 
of 57.8 (see Table 1). Slightly over half of the sample was fe-
male. The sample was ethnically diverse and relatively well-
educated with approximately 3 years of college on average, 
although education ranged from 6 years or less to graduate 
degrees. They had been diagnosed with diabetes an average of 
8 years and a majority (70.4%) managed their disease with oral 
medications. The average HbA1C (7.22) indicates that they 
were managing their diabetes fairly well, although their aver-
age BMI of 33 is in the obese range. Only 8.3% meet criteria for 
MDD. Participation in the 21 days of the study was very high 
with 94.17% having complete data for at least 17 of the 21 days 
(98.5% completed 14 or more days).
Daily Diary Measures
Each evening for 21 consecutive days, participants in 
the daily diary study received telephone calls from “di-
ary recorders.” Patients were run in groups (“flights”) that 
were begun on the same night (always a week night). Nine-
teen flights consisting of 5 to 16 patients were run over 24 
months. During the telephone calls, positive affect (PA) was 
measured by 10 items from the Positive Affect subscale of the 
Positive and Negative Affect Scale (PANAS; Watson, Clark, 
& Tellegen, 1988), including interested, excited, strong, en-
thusiastic, proud, alert, inspired, determined, attentive, and 
active, as well as by four additional items of happy, pleased, 
content, and glad. Negative affect (NA) was measured by 10 
items from the Negative Affect subscale of the PANAS, in-
cluding distressed, upset, guilty, scared, hostile, irritable, 
ashamed, nervous, jittery, and afraid, as well as by five addi-
tional items: disappointed, sad, unhappy, troubled, and mis-
erable. The new items were added to improve measurement 
precision across the range of each construct. For each item 
participants were asked to respond on a 5-point scale the ex-
tent to which they experienced that emotion within the past 
24 hours, where 1 = not at all, 2 = a little, 3 = moderately, 4 = 
quite a bit, and 5 = extremely.
Diary participants were given a Roche Accu-Check auto-
mated blood glucose monitor, with strips for 80 tests. They 
tested their blood glucose each morning upon arising (a.m. 
fasting glucose). Readings were stored in the monitor, along 
with the time they tested, and at the end of the 21 days, the 
research assistants returned to the participants’ homes and 
downloaded the glucose readings.
Item Response Analysis of Affect Items
Confirmatory factor analyses were conducted to examine 
the extent to which the new affect items appeared to measure 
the same construct as the PANAS affect items. Item responses 
were modeled as categorical (i.e., as a graded response model) 
using the WLSMV estimator in Mplus 3.13 (Muthén & Muthén, 
1998-2004). Analyses were conducted on the 4087 daily obser-
vations with at least one response under the assumption of 
measurement invariance across days and missingness at ran-
dom given other observed responses. Fit was acceptable. Fur-
ther, all the factor loadings for the new items were above .75, 
comparable to standard measures, indicating that they did ap-
pear to measure the same latent construct as the PANAS items. 
Latent trait estimates (M = 0, SD = 1) from separate single-fac-
tor models for positive and negative affect were then saved for 
further analysis. By using latent trait estimates rather than ob-
served scores, measurement error is minimized from the daily 
responses and the noninterval nature of the response options 
is properly accounted for.
Data Analysis Plan
We conducted a multilevel analysis using SAS PROC 
MIXED to assess the effects of positive and negative mood on 
daily variations in morning blood glucose. We separated each 
measure of mood into two predictors, (a) a between-person 
measure representing the individual’s mean across the 21 days 
[MnNAi for Negative Affect and MnPAi for Positive Affect], 
and (b) a within-person measure representing the individual’s 
deviation for the previous day from his or her 21-day mean 
[(LagNAdi – MnNAi) for lagged Negative Affect], and [(Lag-
PAdi – MnPAi) for lagged Positive Affect]. The between-per-
son measures are centered around the grand mean by virtue of 
the latent variable constructed from the IRT. The within-per-
son variables were centered about the person’s mean: a higher 
or lower level represents a higher or lower difference on the 
previous day from the individual’s mean.
This characterization of mood allows us to examine 
whether between-person or within-person differences in mood 
are related to blood glucose, for example, whether people with 
higher average levels of negative affect and positive affect 
have higher levels of fasting blood glucose and/or whether 
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people’s daily variation in negative affect and positive affect 
influences fasting blood glucose levels.
Analytic Models
A series of multilevel regression models were used to ex-
amine the relationship between logged morning glucose and 
negative and positive affect. Model A, as shown in Equation 
1, is the regression of morning glucose on negative affect and 
positive affect. 
Level 1:          Ydi = β0i + β1i(LagNAdi – MnNAi) 
  + β2i(LagPAdi – MnPAi) + rdi
Level 2:        β0i = γ00 + γ01(MnNAi) + γ02(MnPAi) + U0i        (1)
 β1i = γ10 + U1i
 β2i = γ20 + U2i 
 
In the Level 1 model, logged morning glucose (Ydi) is a 
function of an individual intercept (β0i), the within-person ef-
fects of negative affect (β1i) and positive affect (β2i), and the re-
sidual morning glucose (rdi) on day d for individual i. In the 
Level 2 model, the individual intercept (β0i) is a function of a 
fixed intercept (γ00), the main effects of between-person posi-
tive and negative affect (γ01 and γ02), and an individual-specific 
random intercept (U0i). The individual effects of within-person 
negative affect (β1i) and positive affect (B2i) are a function of 
the fixed effects (γ10 and γ20) and individual-specific random 
effects of within-person negative and positive affect (U1i and 
U2i). Because the previous day’s negative affect was missing 
for the first day, only 20 days were included.
Model B adds a set of between-person variables to the Level 
2 equations. We added variables in blocks to check for multi-
collinearity, to test for nonlinearity, and examine interactions 
with within-person variables. First we added background 
characteristics (gender, age, education, ethnicity, BMI, time 
with diabetes, and medicine regimen), then we added two in-
dices of depression, MDD diagnosis in the past year and CES-
D symptoms. Finally, HbA1C level and its quadratic value 
were included. We explored a variety of covariance structures, 
a model with random effects for negative and positive affect, a 
first-order autoregressive model (AR1), a set of Toepliz mod-
els, and a model with heterogeneity associated with the be-
tween-person variables (Hoffman, in press; Littell, Milliken, 
Stroup, & Wolfinger, 1996). For distinguishing between nested 
models with varying fixed effects, we used ML estimation; for 
nested models with varying random effects, we use REML es-
timation (Fitzmaurice, Laird, & Ware, 2004).
Results
Table 2 presents between-person correlations for all vari-
ables. These between person correlations represent individu-
als’ means across the 21 days. Gender was not related to any 
of the study variables, but older participants had lower CES-
D scores, had lower mean NA, had been diagnosed with dia-
betes longer than younger participants, and were more likely 
to be on insulin only. Those with higher education were less 
likely to be on insulin only and had lower scores on the CES-
D, but education was not related to either positive or negative 
affect. Of particular interest is the relationship between PA 
and NA and their relationship to CES-D scores. There was a 
small, although significant, negative correlation between mean 
levels of NA and PA (−.16) and both were significantly related 
to the CES-D. CES-D scores were positively related to NA (.56) 
and negatively related to PA (−.24). Neither PA nor NA was 
significantly related to log HbA1C. 
ICCs, representing the proportion of variance between per-
sons, indicate that significant variability exists both between 
and within persons: ICC for positive affect was .71, .57 for neg-
ative affect, and .69 for a.m. glucose. The within-person corre-
lation between negative and positive affect was modest (−.20) 
and the within-person correlations were small, for example, 
the correlations of negative and positive affect with fasting 
glucose were .01 and .05, respectively.
Relationship of Lagged Affect on Morning Glucose
Table 3 provides the parameter estimates for the fixed ef-
fects from Equation 1 and its extensions. The first column, 
Model A, provides the fixed effects of four variables, because 
Table 2. Between Person Correlations: Pearson Correlation Coefficients
 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15
1. AM Glucose  —
2. Negative affect  0.17  —
3. Positive affect  –0.09  –0.16  —
4. Female  0.08  0.06  0.07  —
5. BMI  0.14  0.08  –0.07  0.13  —
6. Education  –0.02  –0.02  0.04  –0.09  –0.01  —
7. Age  –0.17  –0.26  0.04  –0.02  –0.13  0.04  —
8. T DX  0.00  –0.21  0.03  0.02  0.01  –0.06  0.38  —
9. Diet/exercise  –0.08  –0.09  0.04  0.03  –0.07  0.05  –0.06  –0.16  —
10. Pills only  –0.05  0.16  –0.06  –0.01  0.05  0.07  –0.08  –0.21  –0.61  —
11. Insulin only  0.20  –0.10  –0.09  0.02  –0.05  –0.16  0.27  0.43  –0.12  –0.46  —
12. Pills & insulin  –0.01  –0.06  0.15  –0.05  0.05  –0.02  –0.05  0.13  –0.12  –0.46  –0.09  —
13. CES–D  0.21  0.53  –0.25  0.13  0.11  –0.19  –0.20  –0.06  –0.12  0.15  –0.02  –0.08  —
14. MDD  0.06  0.28  –0.15  0.05  0.17  0.06  –0.06  –0.03  –0.07  0.09  –0.09  0.04  0.28  —
15. HbA1C  0.61  0.10  –0.02  0.06  0.08  –0.03  –0.06  0.26  –0.11  –0.17  0.27  0.16  0.14  –0.01  —
Correlations in bold are significant, at least at the 0.05 level.
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both negative and positive affect are each represented by 
two variables: the between-person variable (the average level 
across the 21 days) and the within-person variable (the devi-
ation of the previous day’s affect from their 21-day average). 
Conceptually, at Level 1, daily glucose is a function of an indi-
vidual intercept and the within-person impact of negative and 
positive affect from the previous day. At Level 2, the individ-
ual intercept is a function of the fixed intercept and the main 
effects of between-person negative and positive affect (their 
averages over the 21 days). 
There are significant coefficients for negative affect but not 
positive affect. The between-person coefficient indicates that 
persons higher in their overall level of negative affect across 
the 21 days have higher morning glucose levels, net of posi-
tive affect (“grumpy people” have higher glucose levels). The 
within-person coefficient, although modest, indicates that on 
days in which negative affect was higher than usual, the next 
morning’s glucose was also higher than usual (“grumpy days” 
affect subsequent blood glucose levels). There was no evidence 
of collinearity at either level because of the modest correlation 
between negative and positive affect (within-person r = −.20; 
between-person r = −.20).
We also examined at each stage whether there were inter-
actions between within-person and between-person effects. In 
Model A, we assessed whether levels of positive or negative 
affect moderated the relationship of prior within-person affect 
and subsequent blood glucose, asking if those with high aver-
age negative affect might be more susceptible to having daily 
variations in negative affect exert an influence on the next days 
blood glucose, or whether positive affect might lessen the im-
pact of daily negative affect on blood glucose. No such interac-
tions approached statistical significance.
Model B adds a set of characteristics potentially related to 
average glucose levels and which could interact with daily 
positive and negative affect to influence blood glucose. These 
include standard background variables as well as two indica-
tors of depression, number of recent symptoms (CES-D) and 
diagnosis in the past year (MDD), as well as HbA1C. The ef-
fect of average negative affect is no longer statistically signif-
icant. The magnitude of the within-person effect is similar to 
Model A and remains significant. In addition, time with diabe-
tes, medicine regimen, and HbA1C are significant predictors 
of blood glucose. As time with diabetes increases, there is a 
decrease in average blood glucose, net of HbA1C. Those using 
insulin injections alone had higher blood glucose levels than 
those using diet/exercise, just oral medications, and a combi-
nation of oral medications and insulin injections. As expected, 
higher levels of HbA1C are related to higher glucose up to a 
point, and then the effect levels off.
We examined a series of interactions to assess whether any 
of the between-person characteristics might moderate the ef-
fect of positive or negative affect on blood glucose. Only gen-
der appeared to interact with negative affect. The within-per-
son effect of negative affect appeared to occur for men (.031, p 
< .01) and not for women (.002, ns). It is important to note that 
neither CES-D nor MDD is a significant predictor of blood glu-
cose levels, nor was there any evidence that either moderates 
the affect-glucose relationship.
Relationship of Glucose to Affect
We also examined whether there was a comparable set of 
relationships between blood glucose and subsequent varia-
tions in negative and positive affect, that is, with prior day’s 
blood glucose levels predicting negative and positive affect, 
with the same set of background variables, depression, and 
HbA1C. There is little evidence that average levels of blood 
glucose or daily variations in blood glucose affect negative or 
positive affect, nor that the relationship varied by moderators 
(other Level 2 variables) (tables are available from correspond-
ing author).
Discussion
In this study, we focused in on the daily emotional ups and 
downs in a sample of participants with Type 2 diabetes, giv-
ing us the opportunity to examine the relationship between 
mood and a proximate health outcome: blood glucose. This 
outcome is important both because over time it can have im-
plications for diabetes complications, comorbidities, and mor-
tality and also because it is potentially sensitive to variability 
in mood. There has been little previous work looking at daily 
(state) affect and glucose levels, particularly over such an ex-
tended period of time in a large sample; therefore we set out to 
answer a set of questions about the relationship of both posi-
tive and negative affect to fasting glucose and the direction of 
the relationships.
Between-Person Relationships
The between-person relationship of negative affect and glu-
cose disappeared once the between-person controls were en-
tered into the multilevel analyses. Between person charac-
teristics that remained statistically significant in the analysis 
Table 3. Predictors of Logged AM Glucose (Unstandardized Regres-
sion Weights With Standard Errors)
                                                             A                                    B
Effect                                    Estimate        SE           Estimate          SE
Intercept  4.9136  0.0195***  5.0692  0.0732***
Lagged NA  0.0152  0.0077*  0.0123  0.0057*
Mean NA  0.0673  0.0315*  –0.0148  0.0284
Lagged PA  0.0082  0.0073  0.0023  0.0058
Mean PA  –0.0198  0.0231  –0.0165  0.0183
Female   —   —  0.0220  0.0298
BMI   —   —  0.0005  0.0021
Education   —   —  0.0042  0.0057
Age   —   —  –0.0032  0.0018
TDX   —   —  –0.0068  0.0026**
White vs. Asian   —   —  –0.0731  0.0428
White vs. Black   —   —  –0.0464  0.0406
White vs. Latino   —   —  –0.0127  0.0520
White vs. Other   —   —  –0.0116  0.0562
Insulin vs. Diet/Exer   —   —  –0.1665  0.0770*
Insulin vs. Pills   —   —  –0.1493  0.0682*
Insul. vs. Pills & Insul.   —   —  –0.2535  0.0818**
CESD   —   —  0.0003  0.0018
MDDYR   —   —  0.0035  0.0552
HbA1C   —   —  0.1602  0.0174***
HbA1C sq   —   —  –0.0114  0.0053*
* p < . 05 ; ** p < .01 ; *** p < .001.
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predicting glucose included HbA1C, insulin only, and time 
since diagnosis (negative). Because HbA1C is a standard mea-
sure of glycemic control, it would be expected to be related 
to average daily glucose. Time since diagnosis was positively 
related to blood glucose until we controlled for HbA1C. The 
positive relationship between insulin use and higher levels of 
glucose may represent those having a more difficult time man-
aging their disease.
Within Person Negative Affect and Glucose
The next questions we asked involved within-person anal-
yses that allowed us to examine the lagged effect of both pos-
itive and negative affect on glucose and vice versa. The most 
salient, although modest, finding is the evidence for a lagged 
effect of negative affect on fasting glucose. That is, when indi-
viduals’ levels of negative affect were higher than their own 
average level on one day, their fasting glucose was higher than 
their average on the next morning. In particular, it is notable 
that neither CESD nor MDD was related to glucose, nor did 
they moderate the effect of mood on glucose.
When possible moderators of the negative affect-glucose 
relationship were tested, the only one that was significant was 
gender. Thus, it appears that the effect of previous day’s neg-
ative mood on morning glucose operated for men, but not for 
women. We can only speculate about why this was so. Al-
though women usually show higher levels of depressive af-
fect, there were no significant between person sex differences 
in any of the affective variables, including CES-D, MDD, nega-
tive affect, or positive affect, that might help explain our find-
ings. Women tend to be more expressive of their emotions, 
whereas men tend to hold them inside (Nolen-Hoeksema & 
Jackson, 2001), which might explain the physiological im-
pact of NA. However, rumination also tends to be higher in 
women, which has been linked to cortisol levels (McCullough, 
Orsulak, Brandon, & Akers, 2007) and cortisol, in turn, has 
been linked to fasting glucose in patients with Type 2 diabetes 
(Oltmanns et al., 2006). Because of the number of interactions 
tested, there is the possibility that one could be significant by 
chance, however, a recent publication reported a relationship 
between depression and artherosclerosis for men with Type 1 
diabetes, but not for women (Spitzer et al., 2008). Clearly, this 
unexpected finding warrants further examination.
Positive Affect
There has been increasing evidence for a relationship be-
tween positive affect and health, yet our data do not support 
such a relationship. In the between person analysis, there was no 
relationship between mean levels of positive affect and fasting 
glucose. Likewise, within persons, there were no lagged effects 
of positive affect on next morning glucose. Some research has 
suggested a moderating effect of positive affect on the relation-
ship between negative affect and health outcomes (Valdimars-
dottir & Bougjerg, 1997), but again our data do not support this. 
It may be temperament more than daily fluctuations in state 
positive mood that is operating in other studies that report an 
effect of positive mood on health. As reported from the ICCs, 
the proportion of between person variance was greater for pos-
itive affect than for negative affect (.71 vs. .57), suggesting that 
positive affect may be more of a stable trait than negative affect. 
Although PA may have positive effects on health outcomes, our 
results are consistent with those reported by Yancura, Aldwin, 
Levenson, and Spiro (2006), in which they found no relationship 
between PA and fasting glucose. Finally, it is possible that the 
psychoneuroimmunological concomitants of PA are different 
than those of NA and glucose may be less reactive to positive 
affect. That is, it could be that PA and NA affect different com-
ponents of health differentially.
Reconciling Macroanalytic and Microanalytic Perspectives
In the introduction we discussed the evidence, seen from 
a macroanalytic view, that there is a relationship between de-
pression and diabetes outcomes. How might the data pre-
sented here be related to that view? We have a correlation of 
.56 between CES-D and mean NA across the 21 days, closely 
resembling the relationships reported by a number of investi-
gators between these two constructs (Denollet & deVries, 2006; 
Watson et al., 1988) and a correlation of .61 between mean lev-
els of fasting glucose and HbA1C. Our results are consistent 
with the impact of mood on glucose, but do not provide sup-
port for the impact of glucose on mood. Perhaps our micro-
analytic view provides a glimpse of “allostatic load” in action 
(McEwen, 1998).
Limitations and Conclusions
Among the limitations of this paper are the possible links 
between diabetes and affect that we have not tested here. We 
can only speculate about possible mediating variables be-
tween negative mood and glucose; however, typical models 
suggest that there are behavioral, as well as endocrine and/or 
immunological mediators that could explain this relationship 
(Kiecolt-Glaser & Glaser, 2002; Pressman & Cohen, 2005; Step-
toe & Wardle, 2005; Valdimarsdottir & Bougjerg, 1997). Un-
fortunately, we do not have data to test possible endocrine or 
immune mediators. A future examination will include health 
behaviors. In addition, although this is a relatively large and 
diverse sample, it is limited to those already being treated by 
clinics, thus limiting variability in depressive symptoms, glu-
cose, and affect.
Future research in this area must move toward identify-
ing the mediators in the relationship between negative mood 
and glucose. It also remains to describe the precursors of vari-
ability in mood such as personality traits and environmen-
tal stressors. Nevertheless, the evidence provided here of the 
lagged effect of negative mood on fasting glucose has impli-
cations clinically and for future investigations of the mecha-
nisms linking daily experiences to glycemic control, with the 
potential for contributing to a better understanding of the rela-
tionship between depressive affect and health.
References
Almeida, D. M. (2005). Resilience and vulnerability to daily stress-
ors assessed via diary methods. Current Directions in Psychologi-
cal Science, 14, 64–68.
Anderson, R. J., Freedland, K. E., Clouse, R. E., & Lustman, P. J. 
(2001). The prevalence of comorbid depression in adults with di-
abetes. Diabetes Care, 24, 1069–1078.
Arroyo, C., Hu, F. B., Ryan, L. M., Kawachi, I., Colditz, G. A., 
Speizer, F. E., et al. (2004). Depressive symptoms and risk of 
type 2 diabetes in women. Diabetes Care, 27, 129–133.
272 Sk af f et al. i n He a l tH Ps y c H ol o g y 28 (2009) 
Bode, B. W., Schwartz, S., Stubbs, H. A., & Block, J. E. (2005). Gly-
cemic characteristics in continuously monitored patients with 
type 1 and type 2 diabetes: Normative values. Diabetes Care, 28, 
2361–2366.
Carnethon, M. R., Kinder, L. S., Fair, J. M., Stafford, R. S., & Fort-
mann, S. P. (2003). Symptoms of depression as a risk factor for 
incident diabetes: Findings from the national health and nutri-
tion examination epidemiologic follow-up study, 1971–1992. 
American Journal of Epidemiology, 158, 416–423.
Charles, S. T., & Almeida, D. (2006). Daily reports of symptoms and 
negative affect: Not all symptoms are the same. Psychology & 
Health, 21, 1–17.
Chepenik, L. G., TenHave, T., Oslin, D., Datto, C., Zubritsky, C., 
& Katz, I. R. (2006). A daily diary study of late life depression. 
American Journal of Geriatric Psychiatry, 14, 270–279.
Cohen, S., Kessler, R. C., & Gordon, L. U. (1995). Strategies for mea-
suring stress in studies of psychiatric and physical disorders. In 
S.Cohen, R. C.Kessler, & L. U.Gordon (Eds.), Measuring stress: A 
guide for health and social scientists (pp. 3–26). New York: Oxford 
University Press.
de Groot, M., Anderson, R., Freedland, K. E., Clouse, R. E., & Lust-
man, P. J. (2001). Association of depression and diabetes compli-
cations: A meta-analysis. Psychosomatic Medicine, 63, 619–630.
Denollet, J., & deVries, J. (2006). Positive and negative affect within 
the realm of depression, stress, and fatigue: The two-factor dis-
tress model of the global mood scale (GMS). Journal of Affective 
Disorders, 91, 171–180.
Eaton, W. W. (2002). Epidemiologic evidence on the comorbidity of 
depression and diabetes. Journal of Psychosomatic Research, 53, 
903–906.
Everson-Rose, S. A., Meyer, P. M., Powell, L. H., Pandey, D., Tor-
rens, J. I., Kravity, H. M., et al. (2004). Depressive symptoms, in-
sulin resistance, and risk of diabetes in women at midlife. Diabe-
tes Care, 27, 2856–2862.
Fisher, L., Skaff, M. M., Mullan, J. T., Arean, P., Mohr, D., Masha-
rani, U., et al. (2007). Clinical depression vs. Distress among pa-
tients with type 2 diabetes: Not just a question of semantics. Dia-
betes Care, 30, 542–548.
Fitzmaurice, G., Laird, N. M., & Ware, J. H. (2004). Applied longitudi-
nal analysis. New York: Wiley.
Gonder-Frederick, L. A., Cox, D. J., Bobbitt, S. A., & Pennebaker, J. 
W. (1989). Mood changes associated with blood glucose fluctu-
ations in insulin-dependent diabetes mellitus. Health Psychology, 
8, 45–59.
Hoffman, L. (2007). Multilevel models for examining individual dif-
ferences in within-person variation and covariation over time. 
Multivariate Behavioral Research, 42, 609–629.
Kamarck, T. W., Schwartz, J. E., Shiffman, S., Muldoon, M. F., Sut-
ton-Tyrell, K., & Janicki, D. L. (2005). Psychosocial stress and 
cardiovascular risk: What is the role of daily experience?Journal 
of Personality, 73, 1749–1774.
Kiecolt-Glaser, J. K., & Glaser, R. (2002). Depression and immune 
function: Central pathways to morbidity and mortality. Journal 
of Psychosomatic Research, 53, 873–876.
Kiecolt-Glaser, J. K., McGuire, L., Robles, T. F., & Glaser, R. (2002). 
Psychoneuroimmunology: Psychological influences on immune 
function and health. Journal of Consulting and Clinical Psychology, 
70, 537–547.
Littell, R. C., Milliken, G. A., Stroup, W. W., & Wolfinger, R. D. 
(1996). SAS system for mixed models. Cary, NC: SAS Institute.
Lustman, P. J., & Clouse, R. E. (2005). Depression in diabetic pa-
tients: The relationship between mood and glycemic control. 
Journal of Diabetes and its Complications, 19, 113–122.
McCullough, M. E., Orsulak, P., Brandon, A., & Akers, L. (2007). Ru-
mination, fear, and cortisol: An in vivo study of interpersonal 
transgressions. Health Psychology, 26, 126–132.
McEwen, B. S. (1998). Protective and damaging effects of stress 
mediators,Seminars in Medicine of the Beth Israel Deaconess Medical 
Center (pp. 171–179): Massachusetts Medical Society.
Muthén, B. O., & Muthén, L. K. (1998–2004). Mplus user’s guide (3rd 
ed.). Los Angeles: Muthén & Muthén.
Nolen-Hoeksema, S., & Jackson, B. (2001). Mediators of the gender 
difference in rumination. Psychology of Women, 25, 37–47.
Oltmanns, K. M., Dodt, B., Schultes, B., Raspr, H. H., Schweiger, U., 
Born, J., et al. (2006). Cortisol correlates with metabolic distur-
bances in a population study of type 2 diabetic patients. Euro-
pean Journal of Endocrinology, 154, 325–331.
Palinkas, L. A., Lee, P. P., & Barrett-Connor, E. (2004). A prospective 
study of type 2 diabetes and depressive symptoms in the elderly: 
The Rancho Bernado study. Diabetes Medicine, 21, 1185–1191.
Pressman, S. D., & Cohen, S. (2005). Does positive affect influence 
health?Psychological Bulletin, 131, 925–971.
Radloff, L. S. (1977). The CES-D scale: A self-report depression scale 
for research in the general population. Applied Psychological Mea-
surement, 3, 385–401.
Ryff, C. D., Love, G. D., Urry, H. L., Muller, D., & Rosenkranz, M. A. 
(2006). Psychological well-being and ill-being: Do they have dis-
tinct or mirrored biological correlates?Psychotherapy & Psychoso-
matics, 75, 85–95.
Spitzer, C., Volzke, H., Barnow, S., Krohn, U., Wallaschofsskit, H., 
Ludemann, J., et al. (2008). Association between depression and 
subclinical carotid atherosclerosis in patients with type 1 diabe-
tes. Diabetic Medicine, 25, 349–354.
Steptoe, A., & Wardle, J. (2005). Positive affect and biological junc-
tion in everyday life. Neurobiology of Aging, 26S, S108–S112.
Taylor, S. E., Repetti, R. L., & Seeman, T. (1997). Health psychology: 
What is an unhealthy environment and how does it get under 
the skin?Annual Review of Psychology, 48, 411–447.
Tennen, H., Affleck, G., & Armeli, S. (2005). Personality and daily 
experience revisited. Journal of Personality, 73, 1465–1483.
Trief, P. M., Himes, C. L., Orendorff, R., & Weinstock, R. S. (2001). 
The marital relationship and psychosocial adaptation and gly-
cemic control of individuals with diabetes. Diabetes Care, 24, 
1384–1389.
Valdimarsdottir, H. B., & Bougjerg, D. H. (1997). Positive and nega-
tive mood: Association with natural killer cell activity. Psychol-
ogy & Health, 12, 319–327.
Watson, D. D., Clark, L. A., & Tellegen, A. (1988). Development and 
validation of brief measures of positive and negative affect: The 
PANAS scales. Journal of Personality and Social Psychology, 54, 
1063–1070.
Watson, D. D., Wiese, D., Vaidya, J., & Tellegen, A. (1999). The two 
general activation systems of affect: Structural findings, evolu-
tionary considerations, and psychobiological findings. Journal of 
Personality and Social Psychology, 76, 820–838.
Wittchen, H. U. (1994). Reliability and validity studies of the who: 
Composite intervational diagnostic interview (CIDI): A critical 
review. Journal of Psychiatric Research, 28, 57–84.
Yancura, L. A., Aldwin, C. M., Levenson, M. R., & Spiro, A., III. 
(2006). Coping, affect, and the metabolic syndrome in older 
men: How does coping get under the skin?Journal of Gerontology, 
61B, P295–P303.
